Home
News
Create
Screeners
Insights
EP Biocomposites
117.
95
+6.95
(+6.26%)
Market Cap
₹19.80 Cr
PE Ratio
19.24
Industry
Utilities
Buy
Sell
Company Performance:
1D
+6.26%
1M
-1.71%
6M
-9.27%
1Y
-37.23%
5Y
-29.90%
View Company Insights
Latest news about EP Biocomposites
EP Biocomposites Reports Sharp Revenue Decline in Half-Year Results
5 days ago
EP Biocomposites Limited, listed on the BSE SME platform, reported a significant 46.4% decrease in revenue for the half-year ended September 30, 2025. Revenue from operations fell to Rs 407.48 lakhs from Rs 760.13 lakhs year-over-year. Net profit plummeted by 89% to Rs 9.04 lakhs, with EPS dropping to Rs 0.54 from Rs 4.91. Despite reducing total expenses to Rs 402.64 lakhs, the company couldn't offset the impact of revenue decline. The balance sheet showed decreased cash reserves and increased short-term borrowings. Auditors S.P. Bhandare & Associates found no issues with the financial statements' fair representation.
EP Biocomposites Secures INR 1.25 Crore Contract for ONGC's Goa Convention Center
Jul 25, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation